News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 869
- Sources here
- 18
- Companies here
- 18
Search results
Stored financial headlines
Active search
869 matching headlines
Ticker or company: LAMMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Alamar Biosciences Inc expected to post a loss of 33 cents a share - Earnings Preview
Alamar Biosciences Inc is projected to report a loss of 33 cents per share, according to this earnings preview. The article, sourced from Reuters via Refinitiv, provides an outlook on the company's upcoming financial performance.
ALMR
main company
Sharemaestro market context
Stored weekly price path
18 weeks +50.7%
Alnylam Pharmaceuticals, Inc. (ALNY) latest press releases and corporate news
This article provides a compilation of recent press releases and corporate news related to Alnylam Pharmaceuticals (ALNY). It lists various announcements from the last several months, including financial results, biomarker collaboration reports, webcast details for earnings calls, and updates on neuroscience programs. The page …
ALNY
main company
Sharemaestro market context
Price below Trend Line
52 weeks -49.7% · Next-week setup negative 43.7%
Alamar Biosciences, Inc. - Class A common stock (Nasdaq:ALMR) Stock Quote
This page provides a stock quote for Alamar Biosciences, Inc. (Nasdaq: ALMR), showing its current trading price, daily performance, and key financial metrics like volume and trading ranges. It also lists recent news, including Q2 2026 earnings, partnership announcements, and new product launches, highlighting …
ALMR
main company
Sharemaestro market context
Stored weekly price path
18 weeks +50.7%
ETFs Investing in Lamb Weston Holdings, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Lamb Weston Holdings, Inc. (LW). It provides detailed information for each ETF, including market value, weight of LW in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), current …
LW
main company
Sharemaestro market context
Trend signal active
52 weeks -4.7% · Next-week setup positive 59.2%
Empowered Funds LLC Lowers Stock Position in Alnylam Pharmaceuticals, Inc. $ALNY
Empowered Funds LLC significantly reduced its stake in Alnylam Pharmaceuticals (NASDAQ:ALNY) by 72.2% in the first quarter, selling 14,021 shares and retaining 5,410 shares valued at $1.79 million. Despite this, analysts maintain a "Moderate Buy" consensus rating, although some major firms recently cut their …
ALNY
main company
Sharemaestro market context
Price below Trend Line
52 weeks -49.7% · Next-week setup negative 43.7%
Lamar's Q2 FFO Beat Estimates on Revenue Growth, '26 Guidance Raised
Lamar Advertising Company LAMR posted second-quarter 2026 adjusted funds from operations (AFFO) per share of $2.40, up 8.1% year over year and above the Zacks Consensus Estimate of $2.30 by 4.3%. Net revenues of $616.7 million rose 6.5% and topped the consensus mark of …
LAMR
main company
Sharemaestro market context
Trend signal active
52 weeks +28.8%
Lam Research CEO Timothy Archer sells $9 million in stock
Timothy Archer, President and CEO of Lam Research Corp. (NASDAQ:LRCX), sold 30,000 shares of company stock for $9 million on August 6, 2026, as part of a Rule 10b5-1 trading plan. On the same day, he exercised employee stock options to acquire 30,000 shares …
LRCX
main company
Sharemaestro market context
Trend signal active
52 weeks +233.9% · Next-week setup positive 62.5%
How Investors May Respond To Lamar Advertising (LAMR) Guidance Hike On Strong Q2 And Higher Dividend
Lamar Advertising recently reported second-quarter 2026 results, with sales rising to US$616.75 million and diluted EPS from continuing operations increasing to US$1.58, and it updated full-year 2026 guidance to net income of about US$604.38 million–US$609.38 million and diluted EPS of US$5.95–US$5.99. Management highlighted strong …
LAMR
main company
Sharemaestro market context
Trend signal active
52 weeks +28.8%
Lam Research (NASDAQ: LRCX) CEO trades 30K shares via options
Timothy Archer, President and CEO of Lam Research (NASDAQ: LRCX), recently exercised options for 30,000 shares at $30.0330 and simultaneously sold 30,000 common shares at $300.0000. These transactions were executed under a Rule 10b5-1 trading plan adopted in February 2026. After these trades, Archer …
LRCX
main company
Sharemaestro market context
Trend signal active
52 weeks +233.9% · Next-week setup positive 62.5%
Lam Research Stock Is Gaining Friday: What's Going On?
Lam Research (NASDAQ: LRCX) stock is gaining on Friday, driven by strong fiscal fourth-quarter results that exceeded Wall Street expectations and robust first-quarter guidance fueled by AI-related chipmaking equipment demand. The company reported record revenue, operating margin, and earnings per share, with shares remaining …
LRCX
main company
Sharemaestro market context
Trend signal active
52 weeks +233.9% · Next-week setup positive 62.5%
Wall Street Analysts See Lam Research (LRCX) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Let's …
Sharemaestro market context Trend signal active 52 weeks +205.7%Lam Research Corporation (LRCX) Stock forecasts
Lam Research Corporation (LRCX) is highlighted as one of the largest semiconductor wafer fabrication equipment manufacturers, specializing in deposition and etch technologies. An analyst report from Morningstar on July 31, 2026, suggests buying the stock, indicating that the company's results are improving. The report …
LRCX
main company
Sharemaestro market context
Trend signal active
52 weeks +233.9% · Next-week setup positive 62.5%